Samsung Bioepis’s Ontruzant (biosimilar, trastuzumab) Receives the Health Canada Approval for the Treatment of Breast & Gastric Ca...
February 2, 2022
Accord Launches Zercepac (biosimilar- trastuzumab) in the UK
September 25, 2020
Henlius Present P-III Data of HLX02 (biosimilar- trastuzumab) at ESMO
September 17, 2020
Henlius' HLX02 Receives the NMPA's Approval as the First Trastuzumab Biosimilar in China
August 17, 2020
Samsung Bioepis Launches Ontruzant (trastuzumab- biosimilar) for Early and Metastatic HER2-Overexpressing Breast Cancer in Brazil
August 11, 2020
Insights+ Key Biosimilars Events of May 2020
June 5, 2020
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.